{"schema_version":"secwatch.filing_event.v1","accession":"0001628908-23-000162","form_type":"8-K","ticker":"EVH","cik":"0001628908","company_name":"Evolent Health, Inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.837700+00:00","generated_at":"2026-06-09T00:29:18.258466+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Evolent Q3 revenue $511M (+45% YoY), adjusted EBITDA $48.7M, raises 2023 guidance","bullets":["Revenue $511.0M, up 44.9% YoY; net loss $33.2M (6.5% margin); adjusted EBITDA $48.7M (9.5% margin).","Specialty care revenue grew 80% vs prior year; NIA acquisition contributed ~24% of growth.","Added three new operating partnerships in Q3; total YTD nine vs annual target of six to eight.","Raised mid-point of 2023 revenue and Adjusted EBITDA outlook; confident in $300M run rate by end of 2024.","Total Lives on Platform 78.1M (up from 19.5M YoY); unique members 41.7M (up from 16.6M)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628908-23-000162","json":"https://secwatch.observer/filing/0001628908-23-000162.json","markdown":"https://secwatch.observer/filing/0001628908-23-000162.md","text":"https://secwatch.observer/filing/0001628908-23-000162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000162/0001628908-23-000162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000162/evh-20231102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:29:18.258466+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e6d49ac2b81a11765fdf4fb92214efc215c62f89","claim":"Evolent Health, Inc. updated its the quarter ended September 30, 2023 guidance (raised).","evidence_excerpt":"On November 2, 2023, Evolent Health, Inc. (the \" Company \") issued a press release announcing its financial results for the quarter ended September 30, 2023, a copy of which is furnished herewith as Exhibit 99.1.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000162/0001628908-23-000162-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}